A new clinical trial map is now available on the Clinical Trials Information System (CTIS) public website. The map is intended to offer patients and healthcare professionals with quick access to full, real-time information about clinical trials taking place in their area, hence improving access to clinical research in the European Union.

The map, which builds on CTIS's public information, enhances how individuals use the system and access clinical trial information. Users can search for ongoing studies based on geography and medical conditions. The search engine accepts searches in layman's terms and features an autocorrect mechanism that provides suggestions for misspelled words. Search results include contact information for the investigator, allowing members of the public to inquire directly about potential enrollment in a specific research. The original version of the map is in English. Additional EU languages will be introduced in subsequent editions.

The creation of the map is an action of the Accelerating Clinical Trials in the European Union (ACT EU) initiative workplan for 2025-2026. It responds to requests for a simple, patient-friendly dashboard for CTIS to help stakeholders, particularly patients, locate clinical trials of interest in Europe. EMA hosted a public webinar on 7 March 2025 to provide a live demonstration on how to use all the features. A recording of the session will be available for future reference.

CTIS includes a public searchable database for healthcare professionals, patients and citizens to deliver the high level of transparency foreseen by the Clinical Trials Regulation. The authorisation and oversight of clinical trials is the responsibility of EU/EEA Member States while EMA is responsible for maintaining CTIS. The European Commission oversees the implementation of the Clinical Trials Regulation.

Learn more: New clinical trial map launched in the EU | European Medicines Agency (EMA)